Trex Wind-down, Inc. Share Price

Equities

BPC

US8870802084

Biotechnology & Medical Research

Delayed Deutsche Boerse AG 12:53:45 29/11/2023 pm IST 5-day change 1st Jan Change
0.292 EUR +4.29% Intraday chart for Trex Wind-down, Inc. -.--% -.--%

Financials

Sales 2021 9L 8L 7.4Cr Sales 2022 83.18T 77.72T 69.48L Capitalization 38.92L 36.37L 33Cr
Net income 2021 -1Cr -93.44L -84Cr Net income 2022 -1.9Cr -1.78Cr -158.7Cr EV / Sales 2021 9.89 x
Net cash position 2021 1.41Cr 1.31Cr 117.37Cr Net cash position 2022 87.49L 81.75L 73Cr EV / Sales 2022 -58.4 x
P/E ratio 2021
-1.34 x
P/E ratio 2022
-0.14 x
Employees 9
Yield 2021 *
-
Yield 2022
-
Free-Float 99.37%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.28
Extreme 0.28
2.92
3 years
0.28
Extreme 0.28
51.75
5 years
0.28
Extreme 0.28
184.13
10 years
0.28
Extreme 0.28
184.13
More quotes
Trex Wind-Down, Inc., formerly Timber Pharmaceuticals, Inc., has filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code and is winding down its business. The Company has no operation nor generates any revenue.
More about the company

Quarterly revenue - Rate of surprise